Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi

Sullu, Yuksel; Eraydin, Bilge

Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi

Bilge ERAYDIN, (Erbaa Devlet Hastanesi, Tokat, Türkiye)

Yüksel SÜLLÜ (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Samsun, Türkiye)

Güncel Retina Dergisi

0 0

Yıl: 2021 Cilt: 5 Sayı: 1 Sayfa Aralığı: 43 - 50 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi

Öz:

Retinal vaskülitler, izole olabilecekleri gibi, enfeksiyöz, neoplastik, dejeneratif ve sistemik inflamatuar hastalıklara bağlı olarak gelişebilirler. Enfeksiyöz, non-enfeksiyöz sebeplerin ayırımı uygun tedavi yaklaşımı açısından oldukça önemlidir. Retinal vaskülitlerin tespiti, klinik olarak yapılmakta ve fundus floresein anjiyografi ile doğrulanmaktadır. Non-enfeksiyöz retinal vaskülitlerde, özellikle akut intraoküler inflamasyonun kontrolünde kortikosteroidler temel tedavi yöntemini oluşturmaktadır. Bu derlemenin amacı, non-enfeksiyöz retinal vaskülitlerin klinik bulgularına, tanıya yönelik değerlendirmelerine ve tedavi seçeneklerine genel bir bakış sağlamaktır.

Anahtar Kelime:

Clinical, Diagnosis and Treatment in Non-infectious Retinal Vasculitis

Öz:

Retinal vasculitis can be in the form of isolated ocular involvement, or can be associated with infections, neoplastic, degene rative and systemic inflammatory diseases. The differentiation of infectious and non-infectious causes is very important forthe appropriate treatment approach. Retinal vasculitis is diagnosed clinically and confirmed by fundus fluorescein angiog raphy. Corticosteroids are the main treatment modality in non-infectious retinal vasculitis, especially in the control of acuteintraocular inflammation. The aim of this review is to provide an overview of the clinical findings, diagnostic evaluations andtreatment options of non-infectious retinal vasculitis.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Bibliyografik

1. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509-16.
2. Gass JDM. The Macula. Published by Mosby;1997:663-665.
3. El-Asrar AM, Herbort CP, Tabbara KF. A clinical approach to the diagnosis of retinal vasculitis. Int Ophthalmol. 2010;30(2):149-73.
4. Leder HA, Campbell JP, Sepah YJ, Gan T, Dunn JP, Hatef E, et al. Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis. J Ophthalmic Inflamm Infect. 2013;3(1):30.
5. Khairallah M, Abroug N, Khochtali S, Mahmoud A, Jelliti B, Coscas G, et al. Optical coherence tomography angiıgraphy in patients with Behçet uveitis. Retina. 2017;37(9):1678-1691.
6. Pelegrín L, Hernández-Rodríguez J, Espinosa G, Llorenç V, Sainz-de-laMaza M, Fontenla JR, et al. Characterization of isolated retinal vasculitis. Analysis of a cohort from a single center and literature review. Autoimmun Rev. 2017;16(3):237-243.
7. Palmer HE, Zaman AG, Edelsten CE, Stanford MR, Graham EM. Systemic morbidity in patients with isolated idiopathic retinal vasculitis. Lancet. 1995;346(8973):505-506.
8. Maleki A, Cao JH, Silpa-Archa S, Foster CS. Visual Outcome And Poor Prognostic Factors In Isolated Idiopathic Retinal Vasculitis. Retina. 2016;36(10):1979-85.
9. Chang TS, Aylward GW, Davis JL, Mieler WF, Oliver GL, Maberley AL, et al. Idiopathic retinal vasculitis, aneurysms, and neuroretinitis. Ophthalmology. 1995;102(7):1089-1097.
10. Samuel MA, Equi RA, Chang TS, Mieler W, Jampol LM, Hay D, et al. Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology. 2007;114(8):1526–1529.
11. Singh R, Sharma K, Agarwal A, Dogra M, Gupta V, Sharma A, et al. Vanishing retinal arterial aneurysms with anti-tubercular treatment in a patient with idiopathic retinal vasculitis, aneurysms and neuroretinitis. J Ophthalmic Inflamm Infect. 2016;6(1):8.
12. El-Asrar AM, Jestaneiah S,Al-Serhani AM. Regressionofaneurysmal dilatations in a case of idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN) associated with allergic fungal sinusitis. Eye (Lond). 2004;18(2):197-201.
13. Nourinia R, Montahai T, Amoohashemi N, Hassanpour H, Soheilian M. Idiopathic retinal vasculitis, aneurysms and neuroretinitis syndrome associated with positive perinuclear antineutrophil cytoplasmic antibody. J Ophthalmic Vis Res. 2011;6(4):330–333.
14. Kurz DE, Wang RC, Kurz PA. Idiopathic retinal vasculitis, aneurysms, and neuroretinitis in a patient with antiphospholipid syndrome. Arch Ophthalmol. 2012;130(2):257-258.
15. Hammond MD, Ward TP, Katz B, Subramanian PS. Elevated intracranial pressure associated with idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome. J Neuroophthalmol. 2004;24(3):221–224.
16. Bajgai P, Katoch D, Dogra MR, Singh R. Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: clinical perspectives. Clin Ophthalmol. 2017;11:1805-1817.
17. Yeshurun I, Recillas-Gispert C, Navarro-Lopez P, Arellanes-Garcia L, Cervantes-Coste G. Extensive dynamics in location, shape, and size of aneurysms in a patient with idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome. Am J Ophthalmol. 2003;135(1):118- 120.
18. Jampol LM, Isenberg SJ, Goldberg MF. Occlusive retinal arteriolitis with neovascularization. Am J Ophthalmol. 1978;81(5):583–589.
19. Sanders M. Retinal arteritis,retinal vasculitis and autoimmune retinal vasculitis. Eye (Lond). 1987;1(4):441–465.
20. Rouvas A, Nikita E, Markomichelakis N, Theodossiadis P, Pharmakakis N. Idiopathic retinal vasculitis, arteriolar macroaneurysms and neuroretinitis: clinical course and treatment. J Ophthalmic Inflamm Infect. 2013;3(1):21.
21. Cheema RA, Al-Askar E, Cheema HR. Infliximab therapy for idiopathic retinal vasculitis, aneurysm, and neuroretinitis syndrome. J Ocul Pharmacol Ther. 2011;27(4):407-10.
22. Saatci AO, Ayhan Z, Takeş O, Yaman A, Bajin FM. Single bilateral dexamethasone implant in addition to panretinal photocoagulation and oral azathioprine treatment in IRVAN syndrome. Case Rep Ophthalmol. 2015;6(1):56-62.
23. Ishaq M, Karamat S, Niazi MK. HLA typing in patients of Eales disease. J Coll Physicians Surg Pak. 2005;15(5):288–290.
24. Biswas J, Ravi RK, Naryanasamy A, Kulandai LT, Madhavan HN. Eales’ disease current concepts in diagnosis and management. J Ophthalmic Inflamm Infect. 2013;3(1):11.
25. Rajpal, Singh UB, Mohapatra S, Wagh VK, Porwal C, Kaushik A. Association of Mycobacterium tuberculosis in the causation of Eales’ disease: an institutional experience. Indian J Med Microbiol. 2015;33:43-45.
26. Singh R, Toor P, Parchand S, Sharma K, Gupta V, Gupta A. Quantitative polymerase chain reaction for Mycobacterium tuberculosis in socalled Eales’ disease. Ocul Immunol Inflamm. 2012;20(3):153–157.
27. Saxena S, Pant AB, Khanna VK, Agarwal AK, Singh K, Kumar D, et al. Interleukin-1 and tumor necrosis factor-alpha: novel targets for immunotherapy in Eales disease. Ocul Immunol Inflamm. 2009;17(3):201–206.
28. Cai SJ, Su G, Li H, Xie B, Luo JM. Profiling of human leukocyte antigens in Eales disease and tuberculosis. Int Ophthalmol. 2013;33(5):475-9.
29. Angayarkanni N, Selvi R, Pukhraj R, Biswas J, Bhavesh SJ, Tombran-Tink J. Ratio of the vitreous vascular endothelial growth factor and pigment epithelial derived factor in Eales disease. J Ocul Biol Dis Inform. 2009;2(1):20-28.
30. Gomathy Narayanan I, Saravanan R, Bharathselvi M, Biswas J, Sulochana KN. Localization of Human Copper Transporter 1 in the Eye and its Role in Eales Disease. Ocul Immunol Inflamm. 2016;24(6):678-683.
31. Das T, Pathengay A, Hussain N, Biswas J. Eales’ disease: diagnosis and management. Eye (Lond). 2010;24(3):472-82.
32. Saxena S, Kumar D. New classification system based visual outcome in Eales’ disease. Indian J Ophthalmol. 2007;55(4):267-9.
33. Kharel Sitaula R, Iyer V, Noronha V, Dutta Majumder P, Biswas J. Role of highresolution computerized tomography chest in identifying tubercular etiology in patients diagnosed as Eales’ disease. J Ophthalmic Inflamm Infect. 2017;7(1):4.
34. Biswas J, Reesha KR, Pal B, Gondhale HP, Kharel Sitaula R. Long-Term Outcomes of a Large Cohort of Patients with Eales’ Disease. Ocul Immunol Inflamm. 2018;26(6):870-876.
35. Kleiner RC, Kaplan HL, Shakin JL, Yannuzzi LA, Crosswell HH Jr, McLean WC Jr. Acute frosted retinal periphlebitis. Am J Ophthalmol. 1988;106(1):27-34.
36. Blumenkranz MS, Kaplan HJ, Clarkson JG, Culbertson WW, Williams GA, Kleiner RC, et al. Acute multifocal hemorrhagic retinal vasculitis. Ophthalmology. 1988;95(12):1663–1672.
37. Ghannam MY, Mohammed Naseemuddin M, Weiser P, Mason JO. Acute multifocal hemorrhagic retinal vasculitis in a child: a case report. BMC Ophthalmology. 2016;16(1):181.
38. Johnson MW, Thomley ML, Huang SS, Gass JDM. Idiopathic recurrent branch retinal arterial occlusion. Natural history and laboratory evaluation. Ophthalmology. 1994;101(3):480–489.
39. Rosenbaum JT, Sibley CH, Lin P. Retinal vasculitis. Curr Opin Rheumatol. 2016;28(3):228-35.
40. Shulman S, Kramer M, Amer R, Sorkin N, Schaap-Fogler M, Rosenblatt A, et al. Characteristics and long-term outcome of patients with noninfectious retinal vasculitis. Retina. 2015;35(12):2633-40.
41. Graham E, Stanford MR, Sanders MD, Kasp E, Dumonde DC. A point prevalence study of 150 patients with retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol. 1989;73(9):714-721.
42. Tugal-Tutkun I, Ozdal PC, Oray M, Onal S. Review for Diagnostics of the Year: Multimodal Imaging in Behçet Uveitis. Ocul Immunol Inflamm. 2017;25(1):7-19.
43. Tugal-Tutkun I. Behçet’s Uveitis. Middle East Afr J Ophthalmol. 2009;16(4):219-24.
44. Deuter CM, Kotter I, Wallace GR, Murray PI, Stübiger N, Zierhut M. Behcet’s disease: ocular effects and treatment. Prog Retin Eye Res. 2008;27(1):111–136.
45. Imrie FR, Dick AD. Biologics in the treatment of uveitis. Curr Opin Ophthalmol. 2007;18(6):481-486.
46. Jabs D, Johns C. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol. 1986;102(3):297-301.
47. Kefella H, Luther D, Hainline C. Ophthalmic and neuro-ophthalmic manifestations of sarcoidosis. Curr Opin Ophthalmol. 2017;28(6):587-594.
48. Rodriguez A, Akova YA, Pedroza-Seres M, Foster CS. Posterior segment ocular manifestations in patients with HLA-B27 associated uveitis. Ophthalmology. 1994;101(7):1267-74.
49. Karpik AG, Schwartz MM, Dickey LE, Streeten BW, Roberts JL. Ocular immune reactants in patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1985;35(3):295–312.
50. Asherson RA, Merry P, Acheson JF, Harris EN, Hughes GRV. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the primary antiphospholipid syndrome. Ann Rheum Dis. 1989;48(5):358–361.
51. Abu El-Asrar AM, Naddaf HO, Al-Momen A, Al-Balla SR. Systemic lupus erythematosus flare-up manifesting as a cilioretinal artery occlusion. Lupus. 1995;4(2):158–160.
52. Akova YA, Jabbur NS, Foster CS. Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy. Ophthalmology. 1993;100(12):1775–1781.
53. Harman L, Margo C. Wegener’s granulomatosis. Surv Ophthalmol. 1998;42(5):458-480.
54. Lim LT, Vasudevan V, Shelton J, Vitale AT, Moorthy R. Macula retinal vasculitis and choroiditis associated with granulomatosis with polyangiitis. Retin Cases Brief Rep. 2017;11(2):119-122.
55. Lyons J, Rosenbaum J. Uveitis associated with inflammatory bowel disease. Arch Ophthalmol. 1997;115(1):61-64.
56. Giordano N, D’Ettorre M, Biasi G, Fioravanti A, Moretti L, Marco-longo R. Retinal vasculitis in rheumatoid arthritis: an angiographic study. Clin Exp Rheumatol. 1990;8(2):121–125.
57. Matsuo T, Koyama T, Morimoto N, Umezu H, Matsuo N. Retinal vasculitis as a complication of rheumatoid arthritis. Ophthalmologica. 1990;201(4):196–200.
58. Towler HM, Lightman S. Symptomatic intraocular inflammation in multiple sclerosis. Clin Exp Ophthalmol. 2000;28(2):97–102.
59. Engell T, Andersen PK. The frequency of periphlebitis retinae in multiple sclerosis. Acta Neurol Scand. 1982;65(6):601-608.
60. Arnold AC, Pepose JS, Hepler RS, Foos RY. Retinal periphlebitis and retinitis in·multiple sclerosis: I. Pathological characteristics. Ophthalmology. 1984;91(3):255-262.
61. Engell T, Anderson P . The frequency of periphlebitis retinae in multiple sclerosis. Acta Neurol Scand. 1982;65(6):601-608.
62. Birch MK, Barbosa S, Blumhardt LD, O’Brien C, Harding SP. Retinal venous sheathing and the blood retinal barrier in multiple sclerosis. Arch Ophthalmol. 1996;114(1):34-39.
63. Howe L, Stanford MR, Edelsten C, Graham EM. The efficacy of systemic corticosteroids in sight threatening retinal vasculitis. Eye. 1994;8(4):443- 447.
64. Frère A, Caspers L, Makhoul D, Judice L, Postelmans L, Janssens X, et al. Single Dexamethasone Intravitreal Implant in the Treatment of Noninfectious Uveitis. J Ocul Pharmacol. 2017;33(4):290-297.
65. Fabiani C, Vitale A, Emmi G, Lopalco G, Vannozzi L, Bacherini D, et al. Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema. J Ocul Pharmacol Ther. 2017;33(7):549-555.
66. Fabiani C, Emmi G, Lopalco G, Vannozzi L, Bacherini D, Guerriero S, et al. Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet’s Disease. Isr Med Assoc J. 2017;19(7):415-419.
67. Hemady R, Tauber J, Foster CS. Immunosuppressive drugs in immune and inflammatory ocular disease. Surv Ophthalmol. 1991;35(5):369-385.
68. Ali A, Ku JH, Suhler EB, Choi D, Rosenbaum JT. The course of retinal vasculitis. Br J Ophthalmol. 2014;98(6):785-9.
69. Petropoulos IK, Vaudaux JD, Guex-Crosier Y. Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of Jules Gonin Eye Hospital. 2008;225(5):457-461.
70. Şen HN. Üveitte yeni tedaviler. 38.TOD Nisan Kursu - Uvea Hastalıkları. 2018.
71. Palmer HE, Stanford MR, Sanders MD, Graham EM. Visual outcome of patients with idiopathic ischaemic and non-ischaemic retinal vasculitis. Eye. 1996;10(3):343–348.
72. Kurup S, Lew J, Byrnes G, Yeh S, Nussenblatt R, Levy-Clarke G. Therapeutic efficacy of intravitreal bevacizumab on posterior uveitis complicated by neovascularization. Acta Ophthalmologica. 2009;87(3):349–352.
73. Jeon S, Lee WK. Aggravated capillary non-perfusion after intravitreal bevacizumab for macular edema secondary to systemic lupus erythematosus and anti-phospholipid syndrome. Lupus. 2012;21(3):335–337.
74. Atmaca L, Nagpal P. Eales’ disease: Medical, laser and surgical treatments. Ophthalmol Clin North Am. 1998;11(4):619-626.
75. Becker M, Davis J. Vitrectomy in the treatment of uveitis. Am J Ophthalmol. 2005;140(6):1096-105.

APA	Eraydin B, Sullu Y (2021). Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi. , 43 - 50.
Chicago	Eraydin Bilge,Sullu Yuksel Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi. (2021): 43 - 50.
MLA	Eraydin Bilge,Sullu Yuksel Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi. , 2021, ss.43 - 50.
AMA	Eraydin B,Sullu Y Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi. . 2021; 43 - 50.
Vancouver	Eraydin B,Sullu Y Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi. . 2021; 43 - 50.
IEEE	Eraydin B,Sullu Y "Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi." , ss.43 - 50, 2021.
ISNAD	Eraydin, Bilge - Sullu, Yuksel. "Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi". (2021), 43-50.

APA	Eraydin B, Sullu Y (2021). Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi. Güncel Retina Dergisi, 5(1), 43 - 50.
Chicago	Eraydin Bilge,Sullu Yuksel Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi. Güncel Retina Dergisi 5, no.1 (2021): 43 - 50.
MLA	Eraydin Bilge,Sullu Yuksel Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi. Güncel Retina Dergisi, vol.5, no.1, 2021, ss.43 - 50.
AMA	Eraydin B,Sullu Y Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi. Güncel Retina Dergisi. 2021; 5(1): 43 - 50.
Vancouver	Eraydin B,Sullu Y Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi. Güncel Retina Dergisi. 2021; 5(1): 43 - 50.
IEEE	Eraydin B,Sullu Y "Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi." Güncel Retina Dergisi, 5, ss.43 - 50, 2021.
ISNAD	Eraydin, Bilge - Sullu, Yuksel. "Non-enfeksiyöz Retinal Vaskulitlerde Klinik, Tanı ve Tedavi". Güncel Retina Dergisi 5/1 (2021), 43-50.